Growth Metrics

Boston Scientific (BSX) Long-Term Debt Issuances (2016 - 2025)

Boston Scientific's Long-Term Debt Issuances history spans 14 years, with the latest figure at $1.6 billion for Q1 2025.

  • On a quarterly basis, Long-Term Debt Issuances fell 27.37% to $1.6 billion in Q1 2025 year-over-year; TTM through Dec 2025 was $1.6 billion, a 27.37% decrease, with the full-year FY2025 number at $1.6 billion, down 27.37% from a year prior.
  • Long-Term Debt Issuances hit $1.6 billion in Q1 2025 for Boston Scientific, down from $2.1 billion in the prior quarter.
  • Over the last five years, Long-Term Debt Issuances for BSX hit a ceiling of $3.3 billion in Q1 2022 and a floor of -$1.0 million in Q2 2022.
  • Historically, Long-Term Debt Issuances has averaged $1.7 billion across 3 years, with a median of $1.9 billion in 2024.
  • The widest YoY moves for Long-Term Debt Issuances: up 27.37% in 2025, down 27.37% in 2025.
  • Tracing BSX's Long-Term Debt Issuances over 3 years: stood at -$1.0 million in 2022, then skyrocketed by 214600.0% to $2.1 billion in 2024, then dropped by 27.37% to $1.6 billion in 2025.
  • Business Quant data shows Long-Term Debt Issuances for BSX at $1.6 billion in Q1 2025, $2.1 billion in Q1 2024, and -$1.0 million in Q2 2022.